Tag: hepatitis C virus (HCV)

FDA OK’s Gilead Sciences’s hepatitis C drug for pediatric patients
April 7, 2017 Off

FDA OK’s Gilead Sciences’s hepatitis C drug for pediatric patients

By Dino Mustafić

U.S. Food and Drug Administration (FDA) has approved supplemental indications for Gilead Sciences’s Harvoni (ledipasvir 90 mg/sofosbuvir 400 mg) tablets and Sovaldi (sofosbuvir 400 mg) tablets for the treatment of chronic hepatitis C virus (HCV) infection in adolescents without cirrhosis or with compensated cirrhosis, 12 years of age and older, or weighing at least 35kg.